Develops therapeutics derived from evolutionary outliers in nature, such as plant toxins and peptides, to target cancer and inflammatory diseases. Its clinical-stage pipeline includes novel compounds like PEEL-224, a TOP1 inhibitor, and NET inhibitors, offering potential treatments for conditions with high unmet medical need.
Funding
$63.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The development of effective cancer and inflammatory disease treatments is hindered by the limitations of traditional drug discovery methods. Identifying novel therapeutic compounds with unique mechanisms of action and favorable safety profiles remains a significant challenge.
Solution
Peel Therapeutics leverages evolutionary biology to discover and develop novel therapeutics for cancer and inflammatory diseases. The company's approach involves identifying evolutionary outliers in nature, such as plant toxins and peptides, and translating their unique properties into innovative medicines. Peel's R&D engine focuses on identifying compounds that can circumvent disease mechanisms, offering the potential for more effective and targeted treatments. Their clinical-stage pipeline includes drug candidates with novel mechanisms of action, including TOP1 inhibitors and NET inhibitors.
Target Audience
The primary target audience includes patients with cancer and inflammatory diseases, as well as clinicians and researchers seeking innovative therapeutic options.
Features
- Identification of evolutionary outliers with therapeutic potential through the company's proprietary platform
- Focus on drug candidates with novel mechanisms of action to address unmet medical needs
- Clinical-stage pipeline with ongoing trials for advanced solid tumors
- Development of NET inhibitors to address excessive NETosis in inflammatory conditions
- R&D engine focused on translating nature’s superabilities into medicines